BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES

The invention provides buffered aqueous formulations of bevacizumab. The invention further provides methods of making buffered formulations of bevacizumab. The invention provides methods of treating eye disorders, particularly wet age-related macular degeneration and macular edema by administering t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HEALY-FRIED, MARTHA, YONAN, CHRIS, DENDAMRONGVIT, WIPHUSANEE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides buffered aqueous formulations of bevacizumab. The invention further provides methods of making buffered formulations of bevacizumab. The invention provides methods of treating eye disorders, particularly wet age-related macular degeneration and macular edema by administering the buffered antibody compositions of the disclosure. L'invention concerne des formulations aqueuses tamponnées de bévacizumab. L'invention concerne en outre des procédés de préparation de formulations tamponnées de bévacizumab. L'invention concerne des méthodes de traitement de troubles oculaires, en particulier la dégénérescence maculaire humide liée à l'âge et l'dème maculaire par l'administration des compositions d'anticorps tamponnées de l'invention.